SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 9, 1995 Eli Lilly and Company (Exact name of registrant as specified in its charter) Indiana 1-6351 35-0470950 (State or other jurisdic- (Commission (IRS Employer tion of incorporation) File Number) Identification No.) Lilly Corporate Center, Indianapolis, Indiana 46285 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (317) 276-2000 No Change (Former name or former address, if changed since last report) Item 7. Financial Statements and Exhibits. Exhibit Number Exhibit - ------- ------- (1) Distribution Agreement, dated as of November 9, 1995, among Eli Lilly and Company and Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co., relating to the issuance and sale by Eli Lilly and Company of $500,000,000 aggregate principal amount of its Medium-Term Notes. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ELI LILLY AND COMPANY (Registrant) By: /s/ Edwin W. Miller ----------------------------------- Edwin W. Miller Vice President and Treasurer Dated: November 22, 1995 3 Exhibit Index Exhibit Description Number of Exhibit Page - ------- ----------- ---- (1) Distribution Agreement, dated as of November 9, 1995, among Eli Lilly and Company and Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co., relating to the issuance and sale by Eli Lilly and Company of $500,000,000 aggregate principal amount of its Medium-Term Notes. 4